BioPlus Co Ltd (099430)

Currency in KRW
3,950
-140(-3.42%)
Delayed Data·
Advertisement
099430 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3,9004,090
52 wk Range
3,7858,350
Key Statistics
Bid/Ask
3,935.00 / 3,950.00
Prev. Close
4,090
Open
4,015
Day's Range
3,900-4,090
52 wk Range
3,785-8,350
Volume
219.23K
Average Volume (3m)
438.53K
1-Year Change
-45.1389%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
099430 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Healthcare Equipment & Supplies industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
14/05/2026
EPS / Forecast
104.00 / --
Revenue / Forecast
26.51B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 138.98%
Dividend Yield
1.71%
Industry Median 1.08%
Annualised payout
70.00
Paid annually
5-Years Growth
-
Growth Streak

BioPlus (099430) Income Statement & Profits

Compare 099430 to Peers and Sector

Metrics to compare
099430
Peers
Sector
Relationship
P/E Ratio
18.0x7.8x−0.4x
PEG Ratio
−0.300.010.00
Price/Book
1.4x0.8x2.6x
Price / LTM Sales
2.7x1.0x3.0x
Upside (Analyst Target)
-70.5%49.7%
Fair Value Upside
Unlock40.3%7.3%Unlock

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; Slim Slimmer, a lipolysis solution; LumiDew, a whitening solution; JuveniHill, an anti-wrinkle solution; and hair scalp care, hair treatment, hair nutrition solutions under the BelloHa and BellaChe names, as well as cosmetics comprising heparinoid essence, EGF ball, and skin care gel under the La Bella name. The company was founded in 2003 and is based in Seongnam-si, South Korea.

Employees
145

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
611.43K0.99%2.52B
Other Institutional Investors
2.86M4.65%11.78B
Public Companies & Retail Investors
58.07M94.35%238.94B
Total
61.54M100.00%253.24B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
The Korea Securities Finance Corporation3.98%2,450,27910,082,898
Dimensional Fund Advisors LP0.99%610,6912,512,993

FAQ

What Is the BioPlus (KOSDAQ: 099430) Share Price Today?

The BioPlus stock price today is 3,950 KRW.

What Stock Exchange Does BioPlus (099430) Trade On?

BioPlus is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for BioPlus?

The stock symbol (also called a 'ticker') for BioPlus is "099430."

Does BioPlus Pay Dividends? What’s The Current 099430 Dividend Yield?

Yes, 099430 Pays Dividends to its Shareholders. The current BioPlus dividend yield is 1.7%.

What Is the Current BioPlus Market Capitalisation?

As of today, BioPlus (KOSDAQ: 099430) market cap is 251.7B KRW.

What Is BioPlus's (099430) Earnings Per Share (TTM)?

The BioPlus EPS is currently 139 (Trailing Twelve Months).

When Is the Next BioPlus Earnings Date?

BioPlus's next earnings report will be released on 19/08/2026.

Is 099430 a Buy or Sell From a Technical Analyst Perspective?

Based on today's BioPlus moving averages and other technical indicators, the daily buy/sell signal for 099430 stock is Strong Sell.

How Many Times Has BioPlus Stock Split?

BioPlus has split 1 times. (See the 099430 stock split history page for full effective split date and price information.)

How Many Employees Does BioPlus Have?

BioPlus has 145 employees, based on their latest Companies House report.

What is the current trading status of BioPlus (KOSDAQ: 099430)?

As of 08/07/2026, BioPlus (099430) is trading at a share price of 3,950 KRW, with a previous close of 4,090 KRW. The stock has fluctuated within a day range of 3,900 KRW to 4,090 KRW, while its 52-week range spans from 3,785 KRW to 8,350 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.